PT  - JOURNAL ARTICLE
AU  - Michael Gitlin
AU  - Lori L. Altshuler
AU  - Mark A. Frye
AU  - Rita Suri
AU  - Emily L. Huynh
AU  - Lynn Fairbanks
AU  - Michael Bauer
AU  - Stanley Korenman
TI  - Peripheral thyroid hormones and response to selective serotonin reuptake inhibitors
DP  - 2004 Sep 01
TA  - Journal of Psychiatry and Neuroscience
PG  - 383--386
VI  - 29
IP  - 5
4099  - http://jpn.ca/content/29/5/383.short
4100  - http://jpn.ca/content/29/5/383.full
SO  - JPN2004 Sep 01; 29
AB  - Objective: To examine the relation between baseline measurements of thyroid function and response to selective serotonin reuptake inhibitors (SSRIs) and to consider the effect of these antidepressants on thyroid hormone levels.Methods: Nineteen subjects with major depression, but without a history of thyroid treatment or lithium treatment, were treated openly with either sertraline or fluoxetine in a university-affiliated tertiary care hospital. Hamilton Depression Rating Scale (Ham-D) scores were measured before and after treatment. Clinical Global Impressions (CGI) scores were measured at study end. Thyroid data, consisting of values for thyroid-stimulating hormone (TSH), triiodothyronine (T3, measured by radioimmunoassay [RIA]), thyroxine (T4, measured by RIA) and free T4, were collected before and after treatment. Complete thyroid data were available for 17 subjects. Data were collected during 1997–1999.Results: Baseline TSH correlated strongly with response to treatment as measured by change in Ham-D scores (r = 0.64, p = 0.003). Low TSH values correlated with greater improvement in depressive symptoms. Thyroid hormone levels decreased with treatment, but these decreases did not correlate with clinical improvement.Conclusion: Baseline thyroid function, as measured by serum TSH, may predict a patient’s response to antidepressant treatment with SSRIs. Optimal thyroid function, beyond simply being within the normal laboratory values, may be necessary for an optimal response to antidepressants.